Fate Therapeutics Inc (FATE)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
281,578,000
EV to revenue ratio (TTM)
32.92
EV to ebitda
-2.59
Financial Performance
Revenue (TTM)
6,491,000
Gross profit (TTM)
-77,932,000
EBITDA
-120,502,000
Profitability
Operating margin (TTM)
-1,495.00%
Profit margin
0.00%
Return on assets (TTM)
-26.20%
Return on equity (TTM)
-60.80%
Per Share Metrics
Revenue per share (TTM)
0.05
EPS
-1.05
Diluted EPS (TTM)
-1.05
Book value
1.32
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
PEG ratio
0
Price to sales ratio (TTM)
43.38
Price to book ratio (TTM)
1.901
Growth
Quarterly earnings growth (YoY)
9.20%
Quarterly revenue growth (YoY)
0.00%
Analyst Sentiment
Strong buy
1
Buy
4
Hold
6
Sell
0
Strong sell
0
Risk & Volatility
Beta
2.547